|
Low inflammation, cholesterol cuts heart risk: study ORLANDO, Fla (Reuters) - Patients taking AstraZeneca Plc's Crestor, who saw both their bad cholesterol and a protein tied to arterial inflammation reduced to very low levels, dramatically cut their risk of heart attack, stroke and death, researchers said on Sunday. ReutersACC: Genetic Variability in Clopidogrel Response Not Always Overcome by Dosing ORLANDO (MedPage Today) -- Patients with a genetic variant associated with responsiveness to clopidogrel (Plavix) have double the risk of cardiovascular events even with extreme doses of the drug, according to two studies. Med Page TodayIschemic Heart Failure -- The STICH Findings ORLANDO (MedPage Today) -- This exclusive broadcast focuses on a CABG/CABG-plus-surgery trial to reshape the damaged ventricle that may set a new standard for surgical treatment of patients with ischemic heart failure, plus randomized trials of percutaneous interventions for acute MI. Med Page TodayACC: Surgery for Ischemic Heart Failure Fails to Show Benefit ORLANDO, Fla. (MedPage Today) -- Surgically remodeling swollen ventricles in patients with ischemic heart failure did not save lives or reduce hospitalizations beyond the benefit achieved with bypass surgery alone, researchers said here. Med Page TodayCommunity health centers getting a U.S. booster shot Dozens of community health centers around the region got a boost Friday when the U.S. Department of Health and Human Services announced $338 million in stimulus grants nationally to clinics that care for large numbers of uninsured patients. The Philadelphia InquirerNew study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery Transdermal delivery of estrogen therapy available by prescription 'seems not to alter' the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests. News MedicalMedivir: Epiphany Biosciences Plans On Filing An IND For Valomaciclovir (MIV-606) Targeting MS Epiphany Biosciences plans on filing an IND at the FDA to study the potential impact of valomaciclovir in patients with multiple sclerosis. Valomaciclovir, (EBP-348, MIV-606) is a compound licensed from Medivir (STO:MVIRB). One of the multiple contributing factors to the disease MS can be Epstein-Barr virus (EBV) and valomaciclovir is active against EBV and other herpes viruses. Medical News TodayEndocyte Announces Positive Interim Results From Phase II Clinical Trial Of EC145 In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Endocyte Inc. has announced positive interim results from an ongoing Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer (NSCLC). The single arm Phase II study is designed to evaluate treatment with EC145 in patients with Medical News TodayAllos Therapeutics Submits New Drug Application For Pralatrexate For Patients With Relapsed Or Refractory Peripheral T-cell Lymphoma Allos Therapeutics, Inc. (NASDAQ: ALTH) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of pralatrexate for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Medical News TodayVertex Pharmaceuticals Initiates Phase 2 Development For CFTR Corrector VX-809 In Patients With Cystic Fibrosis Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced the initiation of a Phase 2a clinical trial for VX-809, an investigational Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector that targets the defective CFTR protein that causes cystic fibrosis (CF). Medical News Today1 2 |
Updating news archive ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Popular search keywords in health:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Feedzilla is a news aggregator which categorizes news stories by topic. It is a platform where webmasters and bloggers can find an unmatched selection of easy to use, automatically updating and professional news widgets for their sites. Feedzilla supports the building of widgets in various formats, as well as allowing the addition of news widgets to different blogging platforms and social networks.
Feedzilla manually aggregates news summaries found in RSS feeds, and redistributes them in either RSS format or as a news widget. Content is collected 24 hours a day, 7 days a week from an ever-growing list of providers.
afghan border • air france • airlines jet • almost investigators • any evidence • army takes • arrive iran • atlantic city • authorities seeking • avoid toxic • balloon boy • barack obama • billowing fire • blaze wind • burning fuelstorage • cairo egypt • cancer screening • captured hometown • car bombs • chatham borough • church janitor • city qom • claiming memory • claims memory • cnn viewer • collide egypt • collided outside • complex puerto • countrys interior • death toll • declares swine • died trains • disclosed nuclear • ed hinds • egypt officials • emergency president • emergency white • ensure used • even own • expect death • facility city • facility international • family home • fears grow • fight preceded • flu national • found ny • found slain • fridays earthshaking • fuel storage • fuelstorage site • germanys coalition • girl found • health risk • hn swine • home even • hometown pakistani • hugo ch • identified young • identifying teenager • inspect newly • inspect nuclear • interior ministry • international officials • iran inspect • janitor charged • killing people • lead killer • living outskirts • manhattan claiming • memory home • memory name • murdered almost • name family • national emergency • natoled troops • newly disclosed • northwest airlines • nuclear facility • nuclear site • ny claims • obama declares • officials arrive • officials expect • outside cairo • outskirts burning • own name • peaceful purposes • people died • people evacuated • people living • police cnn • police police • polygamist sect • president barack • priest found • prime minister • publics identifying • puerto rico • qom ensure • raging fire • relocate avoid • residents risk • rev ed • rico fire • rico officials • rico urged • rise countrys • risk fuel • seeking publics • shift put • shrimp vessel • site puerto • site urged • small town • smoke inhalation • smoke still • still billowing • stronghold along • swine flu • taliban chief • taliban chiefs • teenager turned • toll rise • toxic smoke • trains collided • troops seize • turned manhattan • un inspectors • urged relocate • used peaceful • venezuelan president • viewer identified • war crimes • warns health • white house • woman turned • young woman •
9th of September 2009 - Interview of Feedzilla's founder at the IFA in Berlin. [More]